{"id":"https://openalex.org/W4362493428","doi":"https://doi.org/10.1158/1541-7786.c.6540328.v1","title":"Data from The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer","display_name":"Data from The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362493428","doi":"https://doi.org/10.1158/1541-7786.c.6540328.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6540328.v1","doi":"https://doi.org/10.1158/1541-7786.c.6540328.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6540328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1541-7786.c.6540328.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073978983","display_name":"Lewis Chaytor","orcid":"https://orcid.org/0009-0000-4231-0726","observed_orcids":["https://orcid.org/0009-0000-4231-0726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lewis Chaytor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021533016","display_name":"Matthew Simcock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Simcock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080394398","display_name":"Sirintra Nakjang","orcid":"https://orcid.org/0000-0003-2960-6842","observed_orcids":["https://orcid.org/0000-0003-2960-6842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sirintra Nakjang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006487701","display_name":"Richard J. Heath","orcid":"https://orcid.org/0000-0002-1795-1254","observed_orcids":["https://orcid.org/0000-0002-1795-1254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Heath","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Walker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Walker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062478414","display_name":"Craig N. Robson","orcid":"https://orcid.org/0000-0002-9628-6669","observed_orcids":["https://orcid.org/0000-0002-9628-6669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig Robson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100569836","display_name":"Dominic Jones","orcid":"https://orcid.org/0009-0005-0848-2387","observed_orcids":["https://orcid.org/0009-0005-0848-2387"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominic Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062744941","display_name":"Luke Gaughan","orcid":"https://orcid.org/0000-0002-9330-7874","observed_orcids":["https://orcid.org/0000-0002-9330-7874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luke Gaughan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gata2","display_name":"GATA2","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ar-splice-variants","display_name":"androgen receptor splice variants","score":0.9700000286102295},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9160000085830688},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pioneer-transcription-factors","display_name":"pioneer transcription factors","score":0.6460000276565552},{"id":"https://openalex.org/keywords/chromatin-regulation","display_name":"chromatin regulation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/androgen-receptor-reactivation","display_name":"androgen receptor reactivation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/transcriptional-activation","display_name":"transcriptional activation","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.9275027513504028},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7131560444831848},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6663606762886047},{"id":"https://openalex.org/C1292079","wikidata":"https://www.wikidata.org/wiki/Q3817769","display_name":"Transactivation","level":4,"score":0.6132223010063171},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5715559720993042},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.480633407831192},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47258102893829346},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.45021727681159973},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4171302616596222},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.376311719417572},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.36402326822280884},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22879213094711304},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.06628257036209106},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05953866243362427}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6540328.v1","doi":"https://doi.org/10.1158/1541-7786.c.6540328.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6540328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6540328.v1","doi":"https://doi.org/10.1158/1541-7786.c.6540328.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1541-7786.c.6540328.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2919699700","https://openalex.org/W2059586182","https://openalex.org/W7066858205","https://openalex.org/W2741137833","https://openalex.org/W4361958665","https://openalex.org/W2794303722","https://openalex.org/W2601270378","https://openalex.org/W4306641994","https://openalex.org/W3207371227","https://openalex.org/W2103201026"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"androgen":[2],"receptor":[3],"(AR)":[4],"is":[5,51,70,95,102,123,131],"a":[6,71,124],"key":[7,44],"driver":[8],"of":[9,46,56,74,112,127,155],"prostate":[10,27,162],"cancer":[11,28,163],"development.":[12],"Antiandrogens":[13],"effectively":[14],"inactivate":[15],"the":[16,23,54,59,66,80,109],"AR,":[17],"but":[18],"subsequent":[19],"AR":[20,32],"reactivation":[21],"progresses":[22],"disease":[24],"to":[25,133],"castrate-resistant":[26],"(CRPC).":[29],"Constitutively":[30],"active":[31],"splice":[33],"variants":[34],"(AR-V)":[35],"that":[36,65,79,121,164],"function":[37],"unchallenged":[38],"by":[39,104],"current":[40],"AR-targeted":[41],"therapies":[42],"are":[43],"drivers":[45],"CRPC.":[47,115],"Currently,":[48],"very":[49],"little":[50],"known":[52],"about":[53],"regulation":[55,159],"AR-Vs":[57],"at":[58],"chromatin":[60],"level.":[61],"Here,":[62],"we":[63,77],"show":[64],"pioneer":[67],"factor":[68],"GATA2":[69,81,100,113,122,158],"critical":[72,125],"regulator":[73,126],"AR-Vs.":[75],"Furthermore,":[76],"demonstrate":[78],"cistrome":[82],"in":[83,114,142,160],"CRPC":[84,145],"shares":[85],"considerable":[86],"overlap":[87],"with":[88,144],"bromodomain":[89],"and":[90,94,130,157],"extraterminal":[91],"(BET)":[92],"proteins":[93],"codependent":[96],"for":[97],"DNA":[98],"binding.":[99],"activity":[101],"compromised":[103],"BET":[105,134],"inhibitors,":[106,135],"which":[107,146],"attenuates":[108],"pioneering":[110],"role":[111],"In":[116],"all,":[117],"this":[118],"study":[119],"indicates":[120],"AR-V\u2013mediated":[128],"transactivation":[129],"sensitive":[132],"signifying":[136],"these":[137],"agents":[138],"may":[139],"be":[140,166],"efficacious":[141],"patients":[143],"overexpress":[147],"GATA2.":[148],"Implications:":[149],"We":[150],"have":[151],"defined":[152],"novel":[153],"mechanisms":[154],"AR-V":[156],"advanced":[161],"could":[165],"therapeutically":[167],"exploited.":[168]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}